BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 25254396)

  • 1. [Diabetic cardiomyopathy/heart failure: news regarding etiology, diagnosis, therapy].
    Stratmann B; Worms J; Tschoepe D
    Dtsch Med Wochenschr; 2014 Oct; 139(40):2006-9. PubMed ID: 25254396
    [No Abstract]   [Full Text] [Related]  

  • 2. Intracellular lipid accumulation and shift during diabetes progression.
    Wolf P; Winhofer Y; Anderwald CH; Krššák M; Krebs M
    Wien Med Wochenschr; 2014 Aug; 164(15-16):320-9. PubMed ID: 25047370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How Diabetes and Heart Failure Modulate Each Other and Condition Management.
    Randhawa VK; Dhanvantari S; Connelly KA
    Can J Cardiol; 2021 Apr; 37(4):595-608. PubMed ID: 33276047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stage-Based Management of Type 2 Diabetes Mellitus with Heart Failure.
    Osuna PM; Brown SJ; Tabatabai LS; Hamilton DJ
    Methodist Debakey Cardiovasc J; 2018; 14(4):257-265. PubMed ID: 30788011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Diabetes and heart failure: a practically oriented critical appraisal].
    Halle M; Gitt AK; Hanefeld M; Kellerer M; Marx N; Meier JJ; Schumm-Draeger PM; Bramlage P; Tschoepe D
    Dtsch Med Wochenschr; 2012 Mar; 137(9):437-41. PubMed ID: 22354800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Of the renin-angiotensin system and reactive oxygen species Type 2 diabetes and angiotensin II inhibition.
    Leiter LA; Lewanczuk RZ
    Am J Hypertens; 2005 Jan; 18(1):121-8. PubMed ID: 15691626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [From cardiovascular risk to chronic heart failure].
    Ertl G
    Med Klin (Munich); 2003 Oct; 98 Suppl 1():17. PubMed ID: 14694837
    [No Abstract]   [Full Text] [Related]  

  • 8. Impact of diabetes on epidemiology, treatment, and outcomes of patients with heart failure.
    Dei Cas A; Khan SS; Butler J; Mentz RJ; Bonow RO; Avogaro A; Tschoepe D; Doehner W; Greene SJ; Senni M; Gheorghiade M; Fonarow GC
    JACC Heart Fail; 2015 Feb; 3(2):136-45. PubMed ID: 25660838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diabetic Cardiomyopathy: From Mechanism to Management in a Nutshell.
    Khan S; Ahmad SS; Kamal MA
    Endocr Metab Immune Disord Drug Targets; 2021; 21(2):268-281. PubMed ID: 32735531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heart Failure in Type 2 Diabetes Mellitus.
    Kenny HC; Abel ED
    Circ Res; 2019 Jan; 124(1):121-141. PubMed ID: 30605420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implications of Underlying Mechanisms for the Recognition and Management of Diabetic Cardiomyopathy.
    Marwick TH; Ritchie R; Shaw JE; Kaye D
    J Am Coll Cardiol; 2018 Jan; 71(3):339-351. PubMed ID: 29348027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiomyopathy in type 2 diabetes: update on pathophysiological mechanisms.
    Saunders J; Mathewkutty S; Drazner MH; McGuire DK
    Herz; 2008 Apr; 33(3):184-90. PubMed ID: 18568312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diabetic cardiomyopathy revisited.
    Boudina S; Abel ED
    Circulation; 2007 Jun; 115(25):3213-23. PubMed ID: 17592090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Whole body hyperthermia improves obesity-induced insulin resistance in diabetic mice.
    Kokura S; Adachi S; Manabe E; Mizushima K; Hattori T; Okuda T; Nakabe N; Handa O; Takagi T; Naito Y; Yoshida N; Yoshikawa T
    Int J Hyperthermia; 2007 May; 23(3):259-65. PubMed ID: 17523018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Congestive heart failure and diabetes mellitus: an intricated relationship].
    De Flines J; Scheen AJ
    Rev Med Liege; 2007 Feb; 62(2):112-7. PubMed ID: 17461301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of Oxidative Stress in Metabolic and Subcellular Abnormalities in Diabetic Cardiomyopathy.
    Dhalla NS; Shah AK; Tappia PS
    Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32244448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipid metabolism and its implications for type 1 diabetes-associated cardiomyopathy.
    Ritchie RH; Zerenturk EJ; Prakoso D; Calkin AC
    J Mol Endocrinol; 2017 May; 58(4):R225-R240. PubMed ID: 28373293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stem cells and diabetic cardiomyopathy: from pathology to therapy.
    Liu M; Chen H; Jiang J; Zhang Z; Wang C; Zhang N; Dong L; Hu X; Zhu W; Yu H; Wang J
    Heart Fail Rev; 2016 Nov; 21(6):723-736. PubMed ID: 27221074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diabetic cardiomyopathy: a clinical entity or a cluster of molecular heart changes?
    Mizamtsidi M; Paschou SA; Grapsa J; Vryonidou A
    Eur J Clin Invest; 2016 Nov; 46(11):947-953. PubMed ID: 27600276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heartbeat: Diabetes and heart failure.
    Otto CM
    Heart; 2017 Mar; 103(5):327-328. PubMed ID: 28209660
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.